During the past decade, Ziekenhuis Amstelland conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ziekenhuis Amstelland" #1 sponsor was "Borstkanker Onderzoek Groep" with 4 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored and "UMC Utrecht" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis Amstelland" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "BOOG Study Center" with 2 trials as a collaborator, "Ziekenhuis Amstelland" with 2 trials as a collaborator, "ALMANAC Trialists Group" with 1 trials as a collaborator and "AO Research Fund" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Ziekenhuis Amstelland" are "Breast Cancer" (4 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Accidental Fall" (1 trials) and "Aged" (1 trials). Many other conditions were trialed in "Ziekenhuis Amstelland" in a lesser frequency.

Most popular intervention types in "Ziekenhuis Amstelland" are "Drug" (17 trials), "Other" (6 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Fulvestrant" (2 trials), "bococizumab (PF-04950615)" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials) and "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ziekenhuis Amstelland" are 20 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ziekenhuis Amstelland". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ziekenhuis Amstelland, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ziekenhuis Amstelland, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".